Titre :
  • Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response.
Auteur : Delwaide, Jean ; Bourgeois, Nadine ; Gérard, C. ; De Maeght, S ; Mokaddem, F ; Wain, E ; Bastens, Boris ; Fevery, J ; Géhénot, M ; Le Moine, Olivier ; Martinet, J P ; Robaeys, Geert ; Servais, Bruno ; Van Gossum, Marc ; Van Vlierberghe, Hans ; Belgian Association for the Study of the Liver (BASL)
Informations sur la publication : Alimentary pharmacology & therapeutics, 20, 1, (page 15-22)
Statut de publication : Publié, 2004-07
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Acute Disease
Adolescent
Adult
Antiviral Agents -- therapeutic use
Female
Hepatitis C -- drug therapy
Humans
Interferon-alpha -- therapeutic use
Male
Middle Aged
Prospective Studies
Recombinant Proteins
Remission, Spontaneous
Risk Factors
Treatment Outcome
Viral Load
Note : Clinical Trial
Controlled Clinical Trial
Journal Article
Multicenter Study
FLWIN
Langue :
  • Anglais
Identificateurs : urn:issn:0269-2813 
info:doi/10.1111/j.1365-2036.2004.02023.x
info:pii/APT2023
info:pmid/15225166